The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity.
Histone deacetylase 4 (HDAC4) binds and inhibits activation of the critical muscle transcription factor myocyte enhancer factor-2 (MEF2). However, the physiological significance of the HDAC4-MEF2 complex in skeletal muscle has not been established. Here we show that in skeletal muscle, HDAC4 is a critical modulator of MEF2-dependent structural and contractile gene expression in response to neural activity. We present evidence that loss of neural input leads to concomitant nuclear accumulation of HDAC4 and transcriptional reduction of MEF2-regulated gene expression. Cell-based assays show that HDAC4 represses structural gene expression via direct binding to AT-rich MEF2 response elements. Notably, using both surgical denervation and the neuromuscular disease amyotrophic lateral sclerosis (ALS) model, we found that elevated levels of HDAC4 are required for efficient repression of MEF2-dependent structural gene expression, indicating a link between the pathological induction of HDAC4 and subsequent MEF2 target gene suppression. Supporting this supposition, we show that ectopic expression of HDAC4 in muscle fibers is sufficient to induce muscle damage in mice. Our study identifies HDAC4 as an activity-dependent regulator of MEF2 function and suggests that activation of HDAC4 in response to chronically reduced neural activity suppresses MEF2-dependent gene expression and contributes to progressive muscle dysfunction observed in neuromuscular diseases.
Cohen
Todd J
TJ
Department of Pharmacology and Cancer Biology, Box 3813, Duke University Medical Center, Durham, NC 27710, USA.
Barrientos
Tomasa
T
Hartman
Zachary C
ZC
Garvey
Sean M
SM
Cox
Gregory A
GA
Yao
Tso-Pang
TP
D000818:Animals; D002460:Cell Line; D005786:Gene Expression Regulation / Q000502:physiology*; D006655:Histone Deacetylases / Q000235:genetics / Q000378:metabolism*; D064326:MEF2 Transcription Factors; D051379:Mice; D008810:Mice, Inbred C57BL; D032342:Muscle Cells / Q000378:metabolism*; D009154:Mutation; D018006:Myogenic Regulatory Factors / Q000378:metabolism*; D009474:Neurons / Q000502:physiology*; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism*
D064326:MEF2 Transcription Factors; D018006:Myogenic Regulatory Factors; D012097:Repressor Proteins; C400300:HDAC4 protein, human; C498618:Hdac5 protein, mouse; D006655:Histone Deacetylases
Ann Neurol. 2006 Jun;59(6):970-5
16607616
J Biol Chem. 2007 Nov 16;282(46):33752-33759
17873280
Arch Neurol. 1967 Jan;16(1):14-24
6024250
Hum Mol Genet. 2004 Jun 1;13(11):1183-92
15102712
J Biol Chem. 2001 Sep 14;276(37):35042-8
11470791
Science. 1998 Jan 9;279(5348):227-30
9422695
Biochem Biophys Res Commun. 2005 Apr 15;329(3):1001-9
15752755
J Biol Chem. 1999 Apr 23;274(17):12095-102
10207035
Nat Neurosci. 2005 Mar;8(3):313-21
15711539
Physiol Genomics. 2006 Mar 13;25(1):60-74
16380408
Nature. 2000 Nov 2;408(6808):106-11
11081517
Mol Cell Biol. 2005 Oct;25(19):8456-64
16166628
Biochim Biophys Acta. 2006 May;1759(5):240-6
16797743
Mol Cell Biol. 2007 Dec;27(23):8143-51
17875930
Hum Mol Genet. 2006 Aug 1;15(15):2348-62
16801328
Development. 2007 Jul;134(13):2511-9
17537787
Nat Protoc. 2006;1(1):179-85
17406230
J Neurochem. 2005 Jun;93(5):1087-98
15934930
Acta Neuropathol. 1976 Apr 26;34(4):321-7
1274524
J Clin Invest. 2007 Sep;117(9):2459-67
17786239
Nucleic Acids Res. 1997 Apr 15;25(8):1618-25
9092671
Genome Biol. 2003;4(5):P3
12734009
Annu Rev Cell Dev Biol. 1998;14:167-96
9891782
Eur J Biochem. 2001 Feb;268(4):948-57
11179961
EMBO J. 2001 Nov 15;20(22):6414-23
11707412